Palumbo Wealth Management’s CareDx CDNA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$2.36M Buy
82,946
+46,536
+128% +$1.01M 0.49% 42
2026
Q1
$632K Sell
36,410
-9,349
-20% -$177K 0.15% 105
2025
Q4
$862K Buy
45,759
+8,775
+24% +$147K 0.21% 84
2025
Q3
$538K Buy
+36,984
New +$527K 0.17% 84

Other funds holding CDNA

Palumbo Wealth Management's CDNA Position: Q2 2026 in Review

Palumbo Wealth Management increased its CareDx (CDNA) stake by 128% in Q2 2026, buying an estimated $1.01M and bringing the position to 82,946 shares worth $2.36M. The position accounts for 0.49% of the portfolio, ranked #42.

Palumbo Wealth Management first reported a position in CDNA in Q3 2025 and has held it in 4 quarters since. 227 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Palumbo Wealth Management held 82,946 shares of CareDx worth $2.36M as of Q2 2026.
  • Palumbo Wealth Management bought 46,536 CareDx shares in Q2 2026, an estimated $1.01M.
  • CareDx made up 0.49% of Palumbo Wealth Management's portfolio in Q2 2026, its #42 holding.
  • Palumbo Wealth Management first reported a position in CareDx in Q3 2025 and has held it in 4 quarters since.
  • 227 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Palumbo Wealth Management's 13F filing for Q2 2026, filed 12 Aug 2026.